Molecule to Market: Inside the outsourcing space

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO and C-suite leaders from the CDMO ecosystem, exploring the overlooked trends for 2026.   Nick Fortin , CEO, Codis Ankit Gupta , CEO, InstaPill Eric Edwards , MD, PhD, CEO, Phlow USA Dirk T. Lange , CEO, Pyramid Pharma Services Kaan-Fabian Kekec , Partner, Simon-Kucher He...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Banks Bourne, Founder & Chief Executive Officer at Bourne Partners .   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Banks, covering:   How making a bet in the right place at the right time sparked an extraordinary journey in pharm...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Julian Casciano, President & CEO at eMAX Health .   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Julian, covering:   How a family tragedy led him into the healthcare and pharmaceutical world. Why corporate life was not for him, bu...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO and C-suite leaders from the CDMO ecosystem, exploring two simple questions that reveal what’s really happening inside the building: What’s the biggest internal business challenge for the year ahead? And what’s the biggest opportunity inside their business in 2026? Your...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Pep Gubau, CEO, CTO & Co-Founder at Aizon .   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Pep, covering:   How working out what not to do very early on led to two successful growth and exit stories. Why surrounding yourself with...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO/c-suite leaders from the CDMO space, who discuss the big headwinds for the pharmaceutical and biotechnology space for 2026.   Show features: Christiane Bardroff , Chief Operating Officer (COO) at Rentschler Biopharma SE Philip Macnabb , Chief Executive Officer at Curia K...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with three senior leaders that attended The JPM's Annual Healthcare Conference 2026: Chris Garabedian , CEO, Xontogeny and Portfolio Manager, PXV Fund Dean McAlister , Executive Vice President, Inizio Biotech Catherine Hunter , Head of Business Development at  ramarketing   Hear from...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO/c-suite leaders from the CDMO space, who discuss the optimism levels for the pharmaceutical and biotechnology space for 2026.   Guests include: Christiane Bardroff , Chief Operating Officer (COO) at Rentschler Biopharma SE Philip Macnabb , Chief Executive Officer at Curi...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Selin Kurnaz,  Co-Founder and CEO at Massive Bio ,   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Selin, covering:   How a cancer diagnosis in her family led Selin down a path of accidental entrepreneurship, fundraising, and the appli...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jim Gale, Founding Partner & Managing Director at Signet .   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jim, covering: The origins of growth equity in private equity and how it led to the founding of Signet , a fund built on dee...

As we draw close to the end of 2025, our host Raman Sehgal talks about the top 5 episodes of the year.   Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories , and supported by Lead Candidate . Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d al...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Thomas Dobmeyer, medical, entrepreneur and investor at ekwithree .   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Thomas, covering: Choosing to freelance and consult as a medic after qualifying in medicine. Co-founding a niche regulat...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with our host Raman Sehgal. Raman distils dozens of executive conversations across 2025 into three key insights you can take into 2026 for you and your organization.    Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories , and supported by Lead...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Nick Fortin, Chief Executive Officer at Codis . Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Nick, covering: Nick’s desire to scratch that entrepreneurial itch, while recognising he was missing a key tool in his toolbox, which led him...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dr. Fozia Saleem, Chief Executive Officer at Magnitude Biosciences . Your host, Raman Sehgal, speaks with Fozia about the pharmaceutical and biotechnology supply chain, including: How her early roles shaped her focus on applying science and innovation in a practical way The cont...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Andrew Gigax, Head of European Pharma Services M&A at William Blair Jennifer Chadwick, Founder and Principal at Jennifer Chadwick Consulting Sabina Ouimet Storrs, Principal at GHO Capital Partners Jason Foss, Head of Corporate Development at Bora Pharmaceuticals Your host,...

In this episode of Molecule to Market, your host Raman Sehgal discusses the pharmaceutical and biotechnology supply chain with Jean-François Brepson, Chief Executive Officer at PathoQuest . The conversation covers: Navigating 20 years of global leadership roles at Ipsen before moving from the corporate world into an investor-led entrepreneurial adventure The tough decision to refocus PathoQuest fr...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason Anderson, Chief Executive Officer at Ensera .   Your host, Raman Sehgal, speaks with Jason about the pharmaceutical and biotechnology supply chain, covering: Why he chose BASF over law school, and why McKinsey ultimately was not for him Moving from corporate life into a ve...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with our host Raman Sehgal, who discusses the themes and vibe of CPHI 2025 in Frankfurt.     Molecule to Market is also sponsored by Bora Pharma  and Charles River , and supported by  Lead Candidate . Please subscribe, tell your industry colleagues and join us in celebrating and prom...

In this episode of Molecule to Market, you’ll hear wily old wisdom, golden nuggets and invaluable insider tips about CPHI . The nuanced stuff from Veterans of CPHIs gone by you’ll never find in a generic AI-written playbook. The show features: James West, Managing Director, Bourne Partners Arul Ramadurai, CCO at Axplora Christine Fuerst, Director Key Account Management Europe, Vetter Pharma Intern...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gil Roth, President, at Pharma & Biopharma Outsourcing Association ( PBOA ). Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gil, covering: How planned FDA budget cuts and the ongoing US government shutdown are impacting the industry...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with JB Agnus, Chief Commercial Officer at Bora Pharmaceuticals . Your host, Raman Sehgal, speaks with JB about the pharmaceutical and biotechnology supply chain, including: How his global roles taught him the importance of bridging cultures What attracted him to Bora Pharmaceuticals...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Philip Macnabb, Chief Executive Officer at Curia . Your host, Raman Sehgal, speaks with Phil about the pharmaceutical and biotechnology supply chain, covering: Over 25 years of working with private equity — and why PE is ultimately about building sustainable value. The common th...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Lars Petersen, President & Chief Executive Officer at FUJIFILM Biotechnologies .   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Lars, covering: The difficult decision to leave Novo Nordisk and make the jump from one great company...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Matt Lowe, CEO at performance.io / Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Matt, covering: Seeing a niche in SEO, within the healthcare space... and opting to take a risk and jump our of big pharma. Why healthcare agency models a...